{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:42:32Z","timestamp":1780339352577,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.pcl.2021.07.008","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T21:26:17Z","timestamp":1635801977000},"page":"1321-1331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Hepatitis C: Current State of Treatment in Children"],"prefix":"10.1016","volume":"68","author":[{"given":"Sanu R.","family":"Yadav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen F.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4902","key":"10.1016\/j.pcl.2021.07.008_bib1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"issue":"10257","key":"10.1016\/j.pcl.2021.07.008_bib2","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(20)32111-5","article-title":"Nobel Prize for hepatitis C virus discoverers","volume":"396","author":"Burki","year":"2020","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.008_bib4","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jiph.2019.11.015","article-title":"Overview of hepatitis C infection, molecular biology, and new treatment","volume":"13","author":"Rabaan","year":"2020","journal-title":"J\u00a0Infect Public Health"},{"key":"10.1016\/j.pcl.2021.07.008_bib5","doi-asserted-by":"crossref","unstructured":"Fong IW, Fong IW. Blood Transfusion-Associated Infections in the Twenty-First Century: New Challenges. Current Trends and Concerns in Infectious Diseases 2020;191-215. Available at: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7120358\/.","DOI":"10.1007\/978-3-030-36966-8_8"},{"issue":"10","key":"10.1016\/j.pcl.2021.07.008_bib8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1001\/jama.2019.20788","article-title":"Screening for hepatitis C virus infection in adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"323","author":"Chou","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.pcl.2021.07.008_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0040-1709185","article-title":"Hepatitis C virus infection in children and pregnant women: an updated review of the literature on screening and treatments","volume":"10","author":"Ragusa","year":"2020","journal-title":"Am J Perinatol Rep"},{"issue":"5","key":"10.1016\/j.pcl.2021.07.008_bib10","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.039","article-title":"Hepatitis C in pregnancy: screening, treatment, and management","volume":"217","author":"Hughes","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.pcl.2021.07.008_bib11","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of Hepatitis C virus infection: host, viral, and environmental factors","volume":"284","author":"Thomas","year":"2000","journal-title":"J\u00a0Am Med Assoc"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.008_bib12","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/MPG.0b013e318258328d","article-title":"NASPGHAN Practice guidelines: diagnosis and management of hepatitis c infection in infants, children, and adolescents","volume":"54","author":"Mack","year":"2012","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"28","key":"10.1016\/j.pcl.2021.07.008_bib13","first-page":"9245","article-title":"Polymorphisms in the IFNL3\/IL28B gene and hepatitis C: from adults to children","volume":"20","author":"Indolfi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pcl.2021.07.008_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172527","article-title":"Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children","author":"Ruiz-Extremera","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.pcl.2021.07.008_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2020.02.082","article-title":"Treatment of Hepatitis C: a new paradigm toward viral eradication","author":"Squires","year":"2020","journal-title":"J\u00a0Pediatr"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.008_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/hep.28995","article-title":"The safety and effectiveness of ledipasvir\u2212sofosbuvir in adolescents 12-17 years old with hepatitis C virus genotype 1 infection","volume":"66","author":"Balistreri","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.pcl.2021.07.008_bib19","unstructured":"Available at: https:\/\/www.gilead.com\/news-and-press\/press-room\/press-releases\/2021\/6\/us-food-and-drug-administration-approves-new-formulation-of-epclusa-expanding-pediatric-indication-to-treat-children-ages-3-and-older-with-chronic."},{"key":"10.1016\/j.pcl.2021.07.008_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jpeds.2018.12.012","article-title":"Cost effectiveness of early treatment with direct-acting antiviral therapy in adolescent patients with hepatitis C virus infection","volume":"207","author":"Nguyen","year":"2019","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2021.07.008_bib21","article-title":"Treatment of chronic hepatitis C in young children reduces adverse outcomes and is cost-effective compared with deferring treatment to adulthood","author":"Greenaway","year":"2020","journal-title":"J\u00a0Pediatr"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.008_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/MPG.0000000000002814","article-title":"Hepatitis C in 2020: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper","volume":"71","author":"Leung","year":"2020","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"6","key":"10.1016\/j.pcl.2021.07.008_bib23","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1002\/hep.30160","article-title":"Successful treatment with ledipasvir\/sofosbuvir in an infant with severe combined immunodeficiency caused by adenosine deaminase deficiency with HCV allowed gene therapy with Strimvelis","volume":"68","author":"Tucci","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.008_bib24","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1097\/MPG.0000000000002856","article-title":"Sustained virologic remission in an 8-month-old pediatric patient with carbamoyl phosphate synthetase i deficiency and hepatitis c infection using direct-acting antivirals prior to liver transplant","volume":"72","author":"Huang","year":"2021","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.008_bib25","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/hep.30830","article-title":"Ledipasvir-sofosbuvir for 12\u00a0weeks in children 3 to <6 years old with chronic hepatitis C","volume":"71","author":"Schwarz","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.pcl.2021.07.008_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hep.30821","article-title":"Sofosbuvir and ribavirin therapy for children aged 3 to <12 years with hepatitis c virus genotype 2 or 3 infection","volume":"71","author":"Rosenthal","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.pcl.2021.07.008_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/hep.30840","article-title":"Pharmacokinetics, safety, and efficacy of glecaprevir\/pibrentasvir in adolescents with chronic hepatitis C virus: part 1 of the DORA study","volume":"71","author":"Jonas","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.pcl.2021.07.008_bib28","unstructured":"A Phase 2, Open-Label, Multicenter, Multi-cohort Study to Investigate the Safety and Efficacy of Sofosbuvir\/Velpatasvir in Adolescents and Children With Chronic HCV Infection. ClinicalTrials.gov Identifier: NCT03022981. Updated October 8, 2020. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT03022981 Accessed August 19, 2021."},{"issue":"1","key":"10.1016\/j.pcl.2021.07.008_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hep.29109","article-title":"Hepatitis B reactivation in hepatitis B and C coinfected patients treated with antiviral agents: a systematic review and meta-analysis","volume":"66","author":"Chen","year":"2017","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.pcl.2021.07.008_bib30","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S2468-1253(18)30002-5","article-title":"Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395521001152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395521001152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:26:16Z","timestamp":1758475576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395521001152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0031395521001152"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2021.07.008","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C: Current State of Treatment in Children","name":"articletitle","label":"Article Title"},{"value":"Pediatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcl.2021.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}